Skip to main content
SpringerLink
Log in

Telomerase: Biological function and potential role in cancer management

  • Review
  • Published:
Pathology Oncology Research

Abstract

Telomeres are the specialized ends of eukaryotic chromosomes, thought to have many functions, most importantly serving as a clock signaling entry into cellular senescence. These structures are maintained by the reverse transcriptase telomerase, a peculiar enzyme in both structure, since it contains its own template RNA and function, since it is inactivated in most normal tissues but activated in the vast majority of malignant tumors. These features have made telomerase a subject of intense investigation, both to understand its cellular role and regulation and to exploit its activation in cancer to develop drugs or diagnostic methods based on telomerase. This work gathers all the information currently available in the biological and clinical fields of telomerase research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Blackburn EH; Structure and function of telomeres. Nature 350:569–572, 1991.

    Article  PubMed  CAS  Google Scholar 

  2. Kipling D. (ed): The telomere. Oxford University Press, Oxford, 1995.

    Google Scholar 

  3. Griffith JK, Comeau L, Rosenfield S, et al; Mammalian telomeres end in a large duplex loop. Cell 97:503–514, 1999.

    Article  PubMed  CAS  Google Scholar 

  4. Jun-Ping Liu; Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J 13:2091–2104, 1999.

    Google Scholar 

  5. Blackburn EH; Telomerases. Annu Rev Biochemistry 61:113–129, 1992.

    Article  CAS  Google Scholar 

  6. Bhattacharyya A, Blackburn EH; A functional telomerase RNA swap in vivo reveals the importance of nontemplate RNA domains. Proc Natl Acad Sci USA 94:2823–2827, 1997.

    Article  PubMed  CAS  Google Scholar 

  7. Beattie TL, Zhou W, Robinson MO, et al; Reconstitution of human telomerase activity in vitro. Current Biology 8:177–180, 1998.

    Article  PubMed  CAS  Google Scholar 

  8. Kilian A, Bowtell DD, Abud HE, et al; Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Human Mol Genetic 6:2011–2019, 1997.

    Article  CAS  Google Scholar 

  9. Biessmann H, Walter MF, Mason JM; Drosophila telomere elongation. Ciba Fndn Symp 211:53–70, 1997.

    CAS  Google Scholar 

  10. Zakian VA; Structure, function and replication of Saccharomyces cerevisiae telomeres. Annu Rev Genet 30:141–172, 1996.

    Article  PubMed  CAS  Google Scholar 

  11. Wang J, Xie LY, Allan S, et al; Myc activates telomerase. Genes Dev 12:1769–1774, 1998.

    Article  PubMed  CAS  Google Scholar 

  12. Kyo S, Takakura M, Kanaya T, et al; Estrogen activates telomerase. Cancer Res 59:5917–5921, 1999.

    PubMed  CAS  Google Scholar 

  13. Li H, Cao Y, Berndt MC, et al; Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro. Oncogene 18:6785–6794, 1999.

    Article  PubMed  CAS  Google Scholar 

  14. Van Steensel B, De Lange T; Control of telomere length by the human telomeric protein TRF1. Nature 385:740–743, 1997.

    Article  PubMed  Google Scholar 

  15. Smith S, Giriat I, Schmitt A, et al; Tankyrase, a poly(ADPribose) polymerase at human telomeres. Science 282:1484–487, 1998.

    Article  PubMed  CAS  Google Scholar 

  16. Wynford-Thomas D; p53: Guardian of cellular senescence. J Pathol 180:118–121, 1996.

    Article  PubMed  CAS  Google Scholar 

  17. Li H, Zhao LL., Funder JW, Liu JP; Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem 272:16729–16732, 1997.

    Article  PubMed  CAS  Google Scholar 

  18. Li H, Zhao LL, Yang Z, et al; Telomerase is controlled by protein kinase Calpha in human breast cancer cells. J Biol Chem 273:33436–33442, 1998.

    Article  PubMed  CAS  Google Scholar 

  19. Bickenbach JR, Vornwald D, Bachor C, et al; Telomerase is not an epidermal stem cell marker and is downregulated by calcium. J Invest Dermatol 111:1045–1052, 1998.

    Article  PubMed  CAS  Google Scholar 

  20. Martens UM, Zijlmans JM, Poon SS, et al; Short telomeres on human chromosome 17p. Nature Genet 18:76–80, 1998.

    Article  PubMed  CAS  Google Scholar 

  21. Vaziri H, Schachter F, Uchida I, et al; Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Human Genet 52:661–667, 1993.

    CAS  Google Scholar 

  22. Hahn WC, Counter CM, Lundberg AS, et al; Creation of human tumour cells with defined genetic elements. Nature 400:464–468, 1999.

    Article  PubMed  CAS  Google Scholar 

  23. McKenzie KE, Umbricht CB, Sukumar S; Applications of telomerase research in the fight against cancer. Mol Med Today 5:114–122, 1999.

    Article  PubMed  CAS  Google Scholar 

  24. Davis AJ, Siu LL; Telomerase: therapeutic potential in cancer. Cancer Invest 18:269–277, 2000.

    Article  PubMed  CAS  Google Scholar 

  25. Shay JW, Wright WE; Telomerase activity in human cancer. Curr Opin Oncol 8:66–71, 1996.

    Article  PubMed  CAS  Google Scholar 

  26. Lichtsteiner SP, Lebkowski JS, Vasserot AP; Telomerase: A target for anticancer therapy. Ann NY Acad Sci 886:1–11, 1999.

    Article  PubMed  CAS  Google Scholar 

  27. Minev B, Hipp J, Firat H, et al; Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc Natl Acad Sci 97:4796–4801, 2000.

    Article  PubMed  CAS  Google Scholar 

  28. Hahn WC, Stewart WC, Brooks MW, et al.; Inhibition of telomerase limits the growth of human cancer cells. Nature Med 5:1164–1170, 1999

    Article  PubMed  CAS  Google Scholar 

  29. Duncan VE, Ajmani PS, Hughes JA; Cellular delivery is a major obstacle for oligodeoxynucleotide inhibition of telomerase activity. Anticancer Res 18:4105–4108, 1998.

    PubMed  CAS  Google Scholar 

  30. Sawant SG, Gregoire V, Dhar S, et al; Telomerase activity as a measure for monitoring radiocurability of tumor cells. FASEB J 13:1047–1054, 1999.

    PubMed  CAS  Google Scholar 

  31. Greider CW; Telomere length regulation. Annu Rev Biochem 65:337–365, 1996.

    Article  PubMed  CAS  Google Scholar 

  32. Harley CB, Futcher AB, Greider CW; Telomeres shorten during aging of human fibroblasts. Nature 345:458–460, 1990.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Semmelweis University, Budapest, Hungary

    Vassilios D. Chatziantoniou

Authors
  1. Vassilios D. Chatziantoniou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vassilios D. Chatziantoniou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chatziantoniou, V.D. Telomerase: Biological function and potential role in cancer management. Pathol. Oncol. Res. 7, 161–170 (2001). https://doi.org/10.1007/BF03032344

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03032344

Keywords

Search

Navigation